Interestingly, its overexpression is linked to gain or amplification of chromosome 20q, which has been reported in RCC, and STAT3 inhibition has been shown to decrease BCL2L1 expression in RCC cell lines (36, 43, 44). Here, BCL2L1 is linked to renal cell carcinoma.